Boon or bane? Using antidepressants after stroke

Maturitas. 2021 Nov:153:68-70. doi: 10.1016/j.maturitas.2021.02.005. Epub 2021 Feb 24.

Authors

Osvaldo P Almeida¹, Joshua Jones², Graeme J Hankey², Maree Hackett³

Affiliations

¹ Medical School, University of Western Australia, Australia. Electronic address: osvaldo.almeida@uwa.edu.au.
² Medical School, University of Western Australia, Australia.
³ The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Australia; The University of Central Lancashire, Faculty of Health and Wellbeing, University of Central Lancashire, Preston, UK.

PMID: 33674130
DOI: 10.1016/j.maturitas.2021.02.005

No abstract available

Keywords: Adverse events; Antidepressant; Depression; Fluoxetine; Fractures; Stroke.

Publication types

Editorial

MeSH terms

Antidepressive Agents, Second-Generation / adverse effects*
Antidepressive Agents, Second-Generation / therapeutic use
Depression / drug therapy*
Fractures, Bone / chemically induced*
Humans
Selective Serotonin Reuptake Inhibitors / adverse effects*
Selective Serotonin Reuptake Inhibitors / therapeutic use
Stroke / complications*
Stroke Rehabilitation

Substances

Antidepressive Agents, Second-Generation
Serotonin Uptake Inhibitors